Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

• Ngā kaituhi matua: Nasamon Wanlapakorn (Author), Nungruthai Suntronwong (Author), Harit Phowatthanasathian (Author), Ritthideach Yorsaeng (Author), Preeyaporn Vichaiwattana (Author), Thanunrat Thongmee (Author), Chompoonut Auphimai (Author), Donchida Srimuan (Author), Thaksaporn Thatsanatorn (Author), Suvichada Assawakosri (Author), Sitthichai Kanokudom (Author), Yong Poovorawan (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

In light of intermittent supply shortages of individual vaccines and evidence of rare but serious adverse events after vaccination, heterologous regimens for COVID-19 vaccines have gained significant interest. This study aims to assess the reactogenicity and immunogenicity of the heterologous adenov...